Browsing by Author National Institute of Cancer

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)
1-Jan-2014Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical diseaseElmar A. Joura; Kevin A. Ault; F. Xavier Bosch; Darron Brown; Jack Cuzick; Daron Ferris; Suzanne M. Garland; Anna R. Giuliano; Mauricio Hernandez-Avila; Warner Huh; Ole Erik Iversen; Susanne K. Kjaer; Joaquin Luna; Dianne Miller; Joseph Monsonego; Nubia Munoz; Evan Myers; Jorma Paavonen; Punnee Pitisuttithum; Marc Steben; Cosette M. Wheeler; Gonzalo Perez; Alfred Saah; Alain Luxembourg; Heather L. Sings; Christine Velicer; Medizinische Universitat Wien; University of Kansas Medical Center; Institut d'Investigacio Biomedica de Bellvitge; Indiana University School of Medicine Indianapolis; Barts and The London School of Medicine and Dentistry; Augusta University; University of Melbourne; Moffitt Cancer Center; Instituto Nacional de Salud Publica; University of Alabama; Universitetet i Bergen; Kraeftens Bekaempelse; Kobenhavns Universitet; Fundación Universitaria Sanitas; The University of British Columbia; Institut du Col; National Institute of Cancer; Duke University Medical Center; Helsinki University Hospital; Mahidol University; Institut National de Sante Publique Du Quebec; University of New Mexico Health Sciences Center; Merck & Co., Inc.; Universidad del Rosario
28-Jun-2011End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of ageX. Castellsagué; N. Mũoz; P. Pitisuttithum; D. Ferris; J. Monsonego; K. Ault; J. Luna; E. Myers; S. Mallary; O. M. Bautista; J. Bryan; S. Vuocolo; R. M. Haupt; A. Saah; Institut d'Investigacio Biomedica de Bellvitge; National Institute of Cancer; Mahidol University; Medical College of Georgia; Department of Cyto-colposcopy; Emory University School of Medicine; Duke University School of Medicine; Merck & Co., Inc.
1-Dec-2016Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by regionXavier Castellsagué; Kevin A. Ault; F. Xavier Bosch; Darron Brown; Jack Cuzick; Daron G. Ferris; Elmar A. Joura; Suzanne M. Garland; Anna R. Giuliano; Mauricio Hernandez-Avila; Warner Huh; Ole Erik Iversen; Susanne K. Kjaer; Joaquin Luna; Joseph Monsonego; Nubia Muñoz; Evan Myers; Jorma Paavonen; Punnee Pitisuttihum; Marc Steben; Cosette M. Wheeler; Gonzalo Perez; Alfred Saah; Alain Luxembourg; Heather L. Sings; Christine Velicer; Institut d'Investigació Biomedica de Bellvitge; University of Kansas Medical Center; Indiana University School of Medicine Indianapolis; Barts and The London School of Medicine and Dentistry; Augusta University; Medizinische Universitat Wien; Murdoch Children's Research Institute; Moffitt Cancer Center; Instituto Nacional de Salud Publica; University of Alabama; Helse Bergen Haukeland University Hospital; Københavns Universitet; Fundación Universitaria Sanitas; Institut du Col; National Institute of Cancer; Duke University Medical Center; Helsinki University Hospital; Mahidol University; Institut National de Sante Publique Du Quebec; University of New Mexico Health Sciences Center; Merck & Co., Inc.; Universidad del Rosario